Avid Bioservices Inc (CDMO)

[Threes]

bio

We really don't know what we have.
How Far along are the kts.
Why when the last BOD needed a win so badly did they not even peep about details of Exosomes.
Quiet in the past had not been good for PPHM , IP.
Hope we have a tiger here but not enough details to know. Hope this time it's different.


On the PS targeting again what don't we know.
What are the intentions with regard to NCCN/MSK.

I don't know what we have and in both cases who is interested from current market holders in those spaces.